Serotonin transporter gene polymorphism and antidepressant response

NeuroReport

Volumn 11, Issue 1, 2000, Pages 215-219

  Kwan Kim, Doh ^a   Lim, Shinn Won ^b   Lee, Soyoung ^a   En Sohn, Sung ^a   Kim, Seonwoo ^b   Gyu Hahn, Chang ^c   Carroll, Bernard J ^d,e  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d Pacific Behavioral Research Foundation   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant drug; Major depressive disorder; Serotonin transporter; Serotonin transporter gene polymorphism

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0034677021     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200001170-00042     Document Type: Article

References (25)

1. Amara SG and Kuhar MJ. Annu Rev Neurosci 16, 73-93 (1993).
2. Blakely RD, Berson HE, Fremeau RT Jr et al. Nature 354, 66-70 (1991).
3. Ramamoorthy S, Bauman AL, Moore KR et al. Proc Natl Acad Sci USA 90, 2542-2546 (1993).
4. Lesch KP, Balling U, Gross J et al. J Neural Trans 95, 157-162 (1994).
5. Heils A, Teufel A, Petri S et al. J Neurochem 66, 2621-2624 (1996).
6. Ogilvie AD, Battersby S, Bubb VJ et al. Lancet 347, 731-733 (1996).
7. Little KY, McLaughlin DP, Zhang L et al. Am J Psychiatry 155, 207-213 (1998).
8. Benedetti F, Serretti A, Colombo C et al. Am J Psychiatry 156, 1450-1452 (1999).
9. Smeraldi E, Zanardi R, Benedetti F et al. Mol Psychiatry 3, 508-511 (1998).
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, Revised. Washington, DC: APA, 1987.
11. Robins LN, Helzer JE, Croughan J et al. Arch Gen Psychiatry 38, 381-389 (1981).
12. Folstein MF, Folstein SE and McHugh PR. J Psychiatr Res 12, 189-198 (1975).
13. Hamilton M. J Neural Neurosurg Psychiatry 23, 56-62 (1960).
14. Beutler E, Gelbart T and Kuhl W. Biotechniques 9, 166 (1990).
15. Starr L and Quaranta V. Biotechniques 13, 612-618 (1992).
16. Mead DA, Pey NK, Herrnstadt C et al Biotechnology 9, 657-663 (1991).
17. Birnboim HC. Methods Enzymol 100, 243-255 (1983).
18. Weinstein MC and Fineberg HV. Clinical Decision Analysis. Philadelphia: Saunders, 1980.
19. Lusassen AM, Screaton GR, Julier C et al Hum Mol Genet 4, 501-506 (1995).
20. Piriev NI, Sbib JM and Farber DB. Invest Ophth Vis Sci 39, 463-470 (1998).
21. Kim CH, Kim HS, Cubells JF et al. J Biol Chem 274, 6507-6518 (1999).
22. Meyer J, Wiedemann P, Okladnova O et al. J Neural Transm 105, 1341-1350 (1998).
23. Gelernter J, Kranzler H and Cubells JF. Hum Genet 101, 243-246 (1997).
24. Lesch KP, Bengel D, Heils A et al. Science 274, 1527-1531 (1996).
25. Ramamoorthy S and Blakely RD. Science 285, 763-766 (1999).